US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pyxis Oncology, Inc.

1.06

+0.096710.04%

Post-market: 1.01-0.0500-4.72%19:48 EDT

Volume:743.30K

Turnover:776.26K

Market Cap:65.29M

PE:-0.80

High:1.11

Open:0.9500

Low:0.9200

Close:0.9633

Loading ...

Overview Company News Filings

Top Cancer Stocks to Buy to Boost Your Portfolio's Health

Pyxis Oncology to Present Preclinical Data for Micvo Cancer Drug Candidate

MT Newswires Live

Pyxis Oncology Highlights Strategic Focus on Lead Candidate

Promising Prospects for Pyxis Oncology: Buy Rating Affirmed on Strong Clinical Profile and Strategic Focus

Promising Clinical Developments and Strategic Focus Drive Buy Rating for Pyxis Oncology

Pyxis Oncology Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

U.S. RESEARCH ROUNDUP-AT&T, Brighthouse Financial, ETSY

Pyxis Oncology Advances Cancer Therapeutics with MICVO

Pyxis Oncology Inc : Jefferies Cuts Target Price to $6 From $12

THOMSON REUTERS

Pyxis Oncology (PYXS) Gets a Hold from William Blair

Pyxis Oncology FY Net Income USD -77.331 Million

Pyxis Oncology FY Basic EPS USD -1.32

THOMSON REUTERS

Press Release: Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Pyxis Oncology Inc expected to post a loss of 33 cents a share - Earnings Preview

Pyxis Oncology to Participate at the Leerink Partners Global Healthcare Conference

Pyxis Oncology granted Fast Track designation for PYX-201 monotherapy

Pyxis Oncology Granted FDA Fast Track Designation for Pyx-201 Monotherapy in Patients With Recurrent or Metastatic Head and Neck Cancer

THOMSON REUTERS

Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer

Will Pyxis Oncology (NASDAQ:PYXS) Spend Its Cash Wisely?

Simply Wall St.

Pyxis Oncology initiates new PYX-201 trial, initiates cohort expansions

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PYXS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PYXS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PYXS\",,,,,undefined,":{"symbol":"PYXS","market":"US","secType":"STK","nameCN":"Pyxis Oncology, Inc.","latestPrice":1.06,"timestamp":1745265600000,"preClose":0.9633,"halted":0,"volume":743296,"hourTrading":{"tag":"盘后","latestPrice":1.01,"preClose":1.06,"latestTime":"19:48 EDT","volume":777,"amount":816.3275,"timestamp":1745279315595},"delay":0,"floatShares":44339648,"shares":61590415,"eps":-1.323124,"marketStatus":"Not Yet Opened","change":0.0967,"latestTime":"04-21 16:00:00 EDT","open":0.95,"high":1.11,"low":0.92,"amount":776256.0488576001,"amplitude":0.197239,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.323124,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":0,"adr":0,"listingDate":1633665600000,"exchange":"NASDAQ","adjPreClose":0.9633,"preHourTrading":{"tag":"盘前","latestPrice":0.94,"preClose":0.9633,"latestTime":"08:00 EDT","volume":62,"amount":58.279999999999994,"timestamp":1745236809140},"postHourTrading":{"tag":"盘后","latestPrice":1.01,"preClose":1.06,"latestTime":"19:48 EDT","volume":777,"amount":816.3275,"timestamp":1745279315595},"volumeRatio":2.283285,"impliedVol":0.1049,"impliedVolPercentile":0.036},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PYXS\",,,,,undefined,":{"symbol":"PYXS","floatShares":44339648,"roa":"-24.77%","roe":"-62.75%","lyrEps":-1.323124,"volumeRatio":2.283285,"shares":61590415,"dividePrice":0,"high":1.11,"amplitude":0.197239,"preClose":0.9633,"low":0.92,"week52Low":0.8332,"pbRate":"0.54","psRate":"4.04","week52High":5.3899,"institutionHeld":0,"latestPrice":1.06,"eps":-1.323124,"divideRate":0,"volume":743296,"delay":0,"ttmEps":-1.323124,"open":0.95,"prevYearClose":1.56,"prevWeekClose":0.9633,"prevMonthClose":0.9799,"prevQuarterClose":0.9799,"fiveDayClose":0.9587,"twentyDayClose":1.21,"sixtyDayClose":1.64},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PYXS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527225559","title":"Top Cancer Stocks to Buy to Boost Your Portfolio's Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2527225559","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527225559?lang=en_us&edition=fundamental","pubTime":"2025-04-16 21:45","pubTimestamp":1744811100,"startTime":"0","endTime":"0","summary":"An updated edition of the March 7, 2025, article.The cancer market is seeing significant growth and evolution as there is a rising demand for targeted, less toxic cancer medicines. According to the American Cancer Society, 2024 was the first time that new cancer cases in the United States were expected to cross the 2-million mark. This resulted in a massive increase in the global spending on cancer medicines.Verastem Oncology’s new drug application  seeking approval of its novel combination regimen of avutometinib plus defactinib for treating KRAS mutant recurrent low-grade serous ovarian cancer , a rare and distinct type of ovarian cancer, is under priority review with the FDA. The FDA’s decision on the NDA is expected on June 30, 2025. Avutometinib is an RAF/M","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/top-cancer-stocks-buy-boost-134500112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0795875169.SGD","LU0820561818.USD","LU0306806265.USD","MBC","LU1066051498.USD","IE00BVYPNW00.USD","LU0456855351.SGD","BK4107","L","LU0029864427.USD","LU0949170772.SGD","SG9999002232.USD","IE00BFTCPJ56.SGD","LU1894683264.USD","PYXS","BK4534","LU1003077747.HKD","LU0321505439.SGD","LU0203347892.USD","LU1023059063.AUD","LU0795875086.SGD","SGXZ57979304.SGD","LU1496350171.SGD","LU2462157665.USD","LU1244550221.USD","LU2237443465.HKD","AZN","ABBV","VSTM","LU2237443622.USD","LU0310800379.SGD","LU1496350502.SGD","LU1839511570.USD","RLAY","LU0868494617.USD","LU0912757837.SGD","LU0320765992.SGD","BK4588","NVS","LU2089984988.USD","LU0203345920.USD","LU1057294990.SGD","LU1093756168.USD","IE00BJT1NW94.SGD","LU2417539215.USD","BK4599","BK4550","LU1934455863.HKD","LU0234570918.USD"],"gpt_icon":1},{"id":"2522836901","title":"Pyxis Oncology to Present Preclinical Data for Micvo Cancer Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522836901","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522836901?lang=en_us&edition=fundamental","pubTime":"2025-03-26 05:38","pubTimestamp":1742938727,"startTime":"0","endTime":"0","summary":"Pyxis Oncology  said Tuesday it will present new preclinical data from its phase 1 study of micvotabart pelidotin, antibody-drug conjugate to treat recurrent and metastatic head and neck squamous cell carcinoma, at the American Association for Cancer Research Meeting in Chicago in April.In phase 1 trial, the drug showed monotherapy effect on multiple tumor types with significant tumor regression, according to the company. It has begun the part 2 monotherapy expansion cohorts of the ongoing Phase 1 to assess Micvo in second-line and third-line recurrent and metastatic head and neck squamous cell carcinoma patients who have received prior platinum and PD-1 inhibitor therapy and those who received prior EGFRi and PD-1 inhibitor therapy.The company added that preliminary data for patients who received prior platinum and PD-1 inhibitor therapy are expected in H2. Preliminary data from those who received prior EGFRi and PD-1 inhibitor therapy are expected in H1 2026.The company said it also ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1066051498.USD","LU0211331839.USD","LU1093756325.SGD","LU1037948541.HKD","LU1989771016.USD","LU2106854487.HKD","LU1974910355.USD","LU0265550946.USD","LU1035773651.USD","LU0965509010.AUD","LU1699723380.USD","LU1917777945.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU1585245621.USD","LU1037948897.HKD","LU1983299246.USD","SG9999001176.USD","LU1941712264.USD","IE00BBT3K403.USD","LU1066051811.HKD","SGXZ57979304.SGD","BK4588","PYXS","LU1116320901.HKD","BK4007","MRK","LU1291159041.SGD","LU0070302665.USD","LU0203345920.USD","LU0320765489.SGD","SG9999014575.USD","IE000M9KFDE8.USD","BK4550","IE00BLSP4239.USD","LU2361044949.HKD","SG9999014559.SGD","LU1934455863.HKD","LU1066053197.SGD","BK4516","LU1929549753.HKD","SG9999002224.SGD","LU0208291251.USD","LU2461242641.AUD","IE00BN8TJ469.HKD","IE00BSNM7G36.USD","LU2023250504.SGD","LU0266013472.USD","SG9999015358.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"2521747557","title":"Pyxis Oncology Highlights Strategic Focus on Lead Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2521747557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521747557?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:57","pubTimestamp":1742817443,"startTime":"0","endTime":"0","summary":"Pyxis Oncology ( ($PYXS) ) has issued an update. On March 24, 2025, Pyxis Oncology updated its corporate presentation, highlighting its focus on ad...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pyxis-oncology-highlights-strategic-focus-on-lead-candidate?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pyxis-oncology-highlights-strategic-focus-on-lead-candidate?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYXS","BK4139"],"gpt_icon":0},{"id":"2520186904","title":"Promising Prospects for Pyxis Oncology: Buy Rating Affirmed on Strong Clinical Profile and Strategic Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2520186904","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520186904?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:15","pubTimestamp":1742386543,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Sean Lee from Citi maintained a Buy rating on Pyxis Oncology (PYXS – Research Report), with a price target of $5.00...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-prospects-for-pyxis-oncology-buy-rating-affirmed-on-strong-clinical-profile-and-strategic-focus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-prospects-for-pyxis-oncology-buy-rating-affirmed-on-strong-clinical-profile-and-strategic-focus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYXS"],"gpt_icon":0},{"id":"2520183208","title":"Promising Clinical Developments and Strategic Focus Drive Buy Rating for Pyxis Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2520183208","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520183208?lang=en_us&edition=fundamental","pubTime":"2025-03-19 19:45","pubTimestamp":1742384741,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Sam Slutsky has maintained their bullish stance on PYXS stock, giving a Buy rating yesterday. Sam Slutsky has given his Buy...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-clinical-developments-and-strategic-focus-drive-buy-rating-for-pyxis-oncology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-clinical-developments-and-strategic-focus-drive-buy-rating-for-pyxis-oncology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYXS"],"gpt_icon":0},{"id":"2520906503","title":"Pyxis Oncology Price Target Maintained With a $5.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2520906503","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520906503?lang=en_us&edition=fundamental","pubTime":"2025-03-19 18:48","pubTimestamp":1742381280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PYXS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 19, 2025 06:48 ET (10:48 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS"],"gpt_icon":0},{"id":"2520294796","title":"U.S. RESEARCH ROUNDUP-AT&T, Brighthouse Financial, ETSY","url":"https://stock-news.laohu8.com/highlight/detail?id=2520294796","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520294796?lang=en_us&edition=fundamental","pubTime":"2025-03-19 15:35","pubTimestamp":1742369743,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-AT&T, Brighthouse Financial, ETSY March 19 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AT&T, B","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nL4N3Q20KN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTMN","LU0081259029.USD","LU1633808545.USD","KRRO","T","LU1712237335.SGD","BK4585","BK4550","LU0109391861.USD","LU2236285917.USD","BK4515","BK4507","LU0158827948.USD","LU2360032135.SGD","TNDM","LU0354030511.USD","RRC","CMG","LU2095319765.USD","IE00B5TLWC47.USD","LU2384288077.EUR","BK4534","LU1778281490.HKD","BK4023","BHF","BK4082","PYXS","BK4220","IE00BFXG1179.USD","LU2458330169.SGD","LU0557290698.USD","LU2065170008.USD","LU2125910336.SGD","LU0472753341.HKD","LU2125154778.USD","BK4567","BK4122","LU0289961442.SGD","FERG","ETSY","LU0965509283.SGD","BK4554","LU1267930730.SGD","LU0342679015.USD","LU1803068979.SGD","LU0861579265.USD","LU1923621640.USD","LU0672654240.SGD","LU0198837287.USD"],"gpt_icon":1},{"id":"2520699006","title":"Pyxis Oncology Advances Cancer Therapeutics with MICVO","url":"https://stock-news.laohu8.com/highlight/detail?id=2520699006","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520699006?lang=en_us&edition=fundamental","pubTime":"2025-03-19 11:55","pubTimestamp":1742356506,"startTime":"0","endTime":"0","summary":"Pyxis Oncology, Inc. ( ($PYXS) ) has released its Q4 earnings. Here is a breakdown of the information Pyxis Oncology, Inc. presented to its investo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pyxis-oncology-advances-cancer-therapeutics-with-micvo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pyxis-oncology-advances-cancer-therapeutics-with-micvo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","PYXS"],"gpt_icon":0},{"id":"2520099742","title":"Pyxis Oncology Inc : Jefferies Cuts Target Price to $6 From $12","url":"https://stock-news.laohu8.com/highlight/detail?id=2520099742","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520099742?lang=en_us&edition=fundamental","pubTime":"2025-03-19 11:54","pubTimestamp":1742356484,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nFWN3Q1154:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PYXS","BK4139"],"gpt_icon":0},{"id":"2520985498","title":"Pyxis Oncology (PYXS) Gets a Hold from William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2520985498","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520985498?lang=en_us&edition=fundamental","pubTime":"2025-03-19 00:25","pubTimestamp":1742315110,"startTime":"0","endTime":"0","summary":"In a report released today, Andy Hsieh from William Blair reiterated a Hold rating on Pyxis Oncology (PYXS – Research Report). The company’s shares...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pyxis-oncology-pyxs-gets-a-hold-from-william-blair?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pyxis-oncology-pyxs-gets-a-hold-from-william-blair?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PYXS"],"gpt_icon":0},{"id":"2520242956","title":"Pyxis Oncology FY Net Income USD -77.331 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2520242956","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520242956?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:47","pubTimestamp":1742298456,"startTime":"0","endTime":"0","summary":"Mar 18 (Reuters) - Pyxis Oncology FY income from operations USD -89.46 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 18-MAR-202510:44:33.797 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nRSDb1QD9p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PYXS"],"gpt_icon":0},{"id":"2520230629","title":"Pyxis Oncology FY Basic EPS USD -1.32","url":"https://stock-news.laohu8.com/highlight/detail?id=2520230629","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520230629?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:30","pubTimestamp":1742297400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nPLXD473B9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PYXS"],"gpt_icon":0},{"id":"2520621313","title":"Press Release: Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2520621313","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520621313?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:30","pubTimestamp":1742297400,"startTime":"0","endTime":"0","summary":"- Recently reported positive preliminary data from Phase 1 dose escalation trial of micvotabart pelidotin , including a confirmed 50% objective response rate by RECIST 1.1 in recurrent and metastatic head and neck squamous cell carcinoma . - Received Fast Track Designation from the U.S. Food and Drug Administration for MICVO for the treatment of adult patients with R/M HNSCC whose disease has progressed following treatment with platinum-based chemotherapy and an anti-PD-1 therapy. - Initiated monotherapy expansion cohorts of MICVO for 2L and 3L R/M HNSCC patients who have received prior platinum-based chemotherapy and prior PD-1 inhibitor therapy with preliminary data expected in 2H25 and 2/3L R/M HNSCC patients who have received prior EGFRi and PD-1 inhibitor therapy with preliminary data expected 1H26","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","IE00BFTCPJ56.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU1430594728.SGD","LU2461242641.AUD","SG9999015341.SGD","LU1585245621.USD","LU2023250843.SGD","SG9999002232.USD","LU2361044865.SGD","PYXS","IE00B4R5TH58.HKD","ADC","LU0053666078.USD","LU1983299246.USD","LU0203345920.USD","LU2324357040.USD","SG9999001176.USD","LU1699723380.USD","LU1093756325.SGD","MRK","LU0238689110.USD","IE00BJJMRZ35.SGD","LU0006306889.USD","SG9999015358.SGD","ORR","SG9999002224.SGD","LU2468319806.SGD","LU2112291526.USD","IE00B2B36J28.USD","IE000M9KFDE8.USD","LU1934455863.HKD","IE00BBT3K403.USD","BK4516","BK4007","LU1941712264.USD","LU2089984988.USD","BK4550","LU0320765646.SGD","LU1066051225.USD","LU2361044949.HKD","LU1934455194.USD","IE0009355771.USD","LU1066051811.HKD","LU1917777945.USD","R","L","LU0070302665.USD","LU2106854487.HKD"],"gpt_icon":0},{"id":"2520752582","title":"Pyxis Oncology Inc  expected to post a loss of 33 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2520752582","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520752582?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:40","pubTimestamp":1742215220,"startTime":"0","endTime":"0","summary":"Pyxis Oncology Inc  expected to post a loss of33cents a share - Earnings Preview Pyxis Oncology Inc PYXS.OQ PYXS.O is expected to show no change in quarterly revenue when it reports  results on March ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nL8N3Q00XV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS"],"gpt_icon":0},{"id":"2516463855","title":"Pyxis Oncology to Participate at the Leerink Partners Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2516463855","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516463855?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:30","pubTimestamp":1741005000,"startTime":"0","endTime":"0","summary":"BOSTON, March  03, 2025  (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/03/3035521/0/en/Pyxis-Oncology-to-Participate-at-the-Leerink-Partners-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS","BK4137","BK4139","BK4231","ADC","BK4080","HCSG"],"gpt_icon":0},{"id":"2514783476","title":"Pyxis Oncology granted Fast Track designation for PYX-201 monotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2514783476","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514783476?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:35","pubTimestamp":1740573315,"startTime":"0","endTime":"0","summary":"Pyxis Oncology (PYXS) announced that the U.S. Food and Drug Administration has granted Fast Track Designation to PYX-201 for the treatment of adult...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pyxis-oncology-granted-fast-track-designation-for-pyx-201-monotherapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pyxis-oncology-granted-fast-track-designation-for-pyx-201-monotherapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IE00B5TLWC47.USD","BK4104","PYXS","IE00BYQQ9H92.USD","FAST","BK4139","BK4567","BK4585","IE00BFXG0V08.USD"],"gpt_icon":0},{"id":"2514083176","title":"Pyxis Oncology Granted FDA Fast Track Designation for Pyx-201 Monotherapy in Patients With Recurrent or Metastatic Head and Neck Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2514083176","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514083176?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:30","pubTimestamp":1740573000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nTUA3LT8KW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PYXS"],"gpt_icon":0},{"id":"2514680834","title":"Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2514680834","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514680834?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:30","pubTimestamp":1740573000,"startTime":"0","endTime":"0","summary":"Designation applies to the treatment of adult patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) whose disease has progressed following treatment with platinum-bas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/26/3032809/0/en/Pyxis-Oncology-Granted-FDA-Fast-Track-Designation-for-PYX-201-Monotherapy-in-Patients-with-Recurrent-or-Metastatic-Head-and-Neck-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","LU2106854487.HKD","LU1430594728.SGD","BK4231","IE00BJJMRZ35.SGD","LU1917777945.USD","LU1066051225.USD","LU1069347547.HKD","SG9999001176.USD","BK4567","LU1291159041.SGD","IE00BBT3K403.USD","LU1934455863.HKD","LU1066051498.USD","LU0211331839.USD","LU1066053197.SGD","ADC","FAST","IE00BLSP4452.SGD","BK4534","LU2112291526.USD","SG9999015341.SGD","LU2089984988.USD","PYXS","SG9999014559.SGD","BK4139","LU1061106388.HKD","SG9999014567.USD","LU2468319806.SGD","SG9999014542.SGD","LU0006306889.USD","LU0058720904.USD","LU0106261372.USD","LU1989772923.USD","IE00BYQQ9H92.USD","LU0265550946.USD","LU0985320562.USD","LU1941712264.USD","IE00BLSP4239.USD","IE00B2B36J28.USD","LU1699723380.USD","L","LU0203345920.USD","LU0320765646.SGD","LU1989772840.SGD","IE0002141913.USD","IE00B4R5TH58.HKD","LU1023059063.AUD","BK4107"],"gpt_icon":1},{"id":"2513273701","title":"Will Pyxis Oncology (NASDAQ:PYXS) Spend Its Cash Wisely?","url":"https://stock-news.laohu8.com/highlight/detail?id=2513273701","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513273701?lang=en_us&edition=fundamental","pubTime":"2025-02-23 20:53","pubTimestamp":1740315184,"startTime":"0","endTime":"0","summary":"There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly.So, the natural question for Pyxis Oncology  shareholders is whether they should be concerned by its rate of cash burn. In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. First, we'll determine its cash runway by comparing its cash burn with its cash reserves.A company's cash runway is calculated by dividing its cash hoard by its cash burn. As at September 2024, Pyxis Oncology had cash of US$145m and no debt. In the last year, its cash burn was US$54m. That means it had a cash runway of about 2.7 years as of September 2024. Arguably, that's a prudent and sensible length of runw","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pyxis-oncology-nasdaq-pyxs-spend-125304365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2095319765.USD","USJW.SI","BK4139","TSYW.SI","LU2210150020.SGD","NVIW.SI","IE00BGHQF748.EUR","USAW.SI","SQQQ","NDAQ","PYXS","QID","BK4112","BK4585","IE00B3QW5Z07.USD","TQQQ","IE00B64PRP62.GBP","QLD","MNQmain","LU2210149790.SGD","NQmain","IE00BKPKM429.USD","PSQ","BK4588",".IXIC"],"gpt_icon":1},{"id":"2508455985","title":"Pyxis Oncology initiates new PYX-201 trial, initiates cohort expansions","url":"https://stock-news.laohu8.com/highlight/detail?id=2508455985","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508455985?lang=en_us&edition=fundamental","pubTime":"2025-02-04 20:37","pubTimestamp":1738672671,"startTime":"0","endTime":"0","summary":"Pyxis Oncology (PYXS) announced significant progress in its clinical program for PYX-201, a first-in-concept antibody-drug conjugate, ADC, that uni...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pyxis-oncology-initiates-new-pyx-201-trial-initiates-cohort-expansions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pyxis-oncology-initiates-new-pyx-201-trial-initiates-cohort-expansions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PYXS"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":64,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PYXS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-18","symbol":"PYXS","fiscalQuarterEnding":"2024/12","expectedEps":-0.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2024-11-12","symbol":"PYXS","fiscalQuarterEnding":"2024/09","expectedEps":-0.32,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2024-08-14","symbol":"PYXS","fiscalQuarterEnding":"2024/06","expectedEps":-0.33,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2024-05-14","symbol":"PYXS","fiscalQuarterEnding":"2024/03","expectedEps":-0.27,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"pre","actualEps":-0.06},{"market":"US","date":"2024-03-21","symbol":"PYXS","fiscalQuarterEnding":"2023/12","expectedEps":-0.49,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1710993600000,"reportTimeType":"pre","actualEps":-0.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PYXS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PYXS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.4286,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":7,"updateTime":1732248000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PYXS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PYXS","date":"2025-04-17","current":-0.743806,"percent":0.8223,"low":-8.295353,"twenty":-3.611995,"median":-1.149569,"eighty":-0.769606,"high":-0.361135,"avg":-2.059917,"sd":1.743018,"marketCap":57519288},"quantilePoints":[{"date":"2021-10-08","current":-8.027761,"twenty":-7.000853,"median":-5.460491,"eighty":-3.942431,"marketCap":423392125},{"date":"2021-10-15","current":-7.158087,"twenty":-7.278503,"median":-7.179372,"eighty":-6.139529,"marketCap":377524644},{"date":"2021-10-22","current":-7.924373,"twenty":-7.797875,"median":-7.194576,"eighty":-7.01456,"marketCap":417939347},{"date":"2021-10-29","current":-8.112904,"twenty":-7.957214,"median":-7.453046,"eighty":-7.096054,"marketCap":427882647},{"date":"2021-11-05","current":-7.346617,"twenty":-8.064251,"median":-7.83923,"eighty":-7.160519,"marketCap":387467944},{"date":"2021-11-12","current":-7.188495,"twenty":-8.027761,"median":-7.453046,"eighty":-7.150789,"marketCap":379128403},{"date":"2021-11-19","current":-6.530285,"twenty":-8.0083,"median":-7.297964,"eighty":-6.572742,"marketCap":416142385},{"date":"2021-11-26","current":-6.489849,"twenty":-7.968161,"median":-7.194576,"eighty":-6.360457,"marketCap":413565652},{"date":"2021-12-03","current":-6.161313,"twenty":-7.92194,"median":-7.161128,"eighty":-6.269642,"marketCap":392629696},{"date":"2021-12-10","current":-4.599504,"twenty":-7.909777,"median":-7.054699,"eighty":-6.108748,"marketCap":293103383},{"date":"2021-12-17","current":-4.29624,"twenty":-7.887883,"median":-6.583356,"eighty":-5.099226,"marketCap":273777885},{"date":"2021-12-23","current":-4.958366,"twenty":-7.83923,"median":-6.472159,"eighty":-4.735973,"marketCap":315971889},{"date":"2021-12-31","current":-5.544677,"twenty":-7.608128,"median":-6.388761,"eighty":-4.857278,"marketCap":353334518},{"date":"2022-01-07","current":-5.104944,"twenty":-7.510822,"median":-6.288084,"eighty":-4.857278,"marketCap":325312546},{"date":"2022-01-14","current":-5.206032,"twenty":-7.39527,"median":-6.161313,"eighty":-4.872441,"marketCap":331754378},{"date":"2022-01-21","current":-4.811789,"twenty":-7.356348,"median":-6.100661,"eighty":-4.857278,"marketCap":306631231},{"date":"2022-01-28","current":-4.25075,"twenty":-7.307695,"median":-5.81256,"eighty":-4.84818,"marketCap":270879060},{"date":"2022-02-04","current":-4.321512,"twenty":-7.259042,"median":-5.504241,"eighty":-4.792582,"marketCap":275388343},{"date":"2022-02-11","current":-3.811017,"twenty":-7.205523,"median":-5.368642,"eighty":-4.623765,"marketCap":242857089},{"date":"2022-02-18","current":-3.654331,"twenty":-7.189711,"median":-5.206032,"eighty":-4.399349,"marketCap":232872248},{"date":"2022-02-25","current":-3.159,"twenty":-7.173899,"median":-5.104944,"eighty":-4.333642,"marketCap":201307268},{"date":"2022-03-04","current":-2.22899,"twenty":-7.160519,"median":-5.074618,"eighty":-4.262881,"marketCap":142042408},{"date":"2022-03-11","current":-2.330078,"twenty":-7.150789,"median":-5.00891,"eighty":-4.128434,"marketCap":148484241},{"date":"2022-03-18","current":-2.754648,"twenty":-7.091189,"median":-4.948257,"eighty":-3.780691,"marketCap":175539938},{"date":"2022-03-25","current":-2.375568,"twenty":-7.01456,"median":-4.892659,"eighty":-3.269185,"marketCap":151383066},{"date":"2022-04-01","current":-1.514143,"twenty":-6.776977,"median":-4.864859,"eighty":-2.912659,"marketCap":115037013},{"date":"2022-04-08","current":-1.594728,"twenty":-6.572742,"median":-4.821897,"eighty":-2.615147,"marketCap":121159431},{"date":"2022-04-14","current":-1.548073,"twenty":-6.514111,"median":-4.811789,"eighty":-2.474634,"marketCap":117614873},{"date":"2022-04-22","current":-1.246941,"twenty":-6.475697,"median":-4.756191,"eighty":-2.394775,"marketCap":94736363},{"date":"2022-04-29","current":-1.038157,"twenty":-6.428186,"median":-4.62983,"eighty":-2.330078,"marketCap":78873989},{"date":"2022-05-06","current":-0.961884,"twenty":-6.388761,"median":-4.480726,"eighty":-2.254263,"marketCap":73079165},{"date":"2022-05-13","current":-0.86541,"twenty":-6.374609,"median":-4.387219,"eighty":-1.911128,"marketCap":61037378},{"date":"2022-05-20","current":-0.951094,"twenty":-6.339557,"median":-4.33162,"eighty":-1.594728,"marketCap":67080683},{"date":"2022-05-27","current":-1.066768,"twenty":-6.294231,"median":-4.29624,"eighty":-1.532805,"marketCap":75239144},{"date":"2022-06-03","current":-1.0582,"twenty":-6.247238,"median":-4.25075,"eighty":-1.347884,"marketCap":74634814},{"date":"2022-06-10","current":-1.02821,"twenty":-6.197705,"median":-4.190098,"eighty":-1.189259,"marketCap":72519657},{"date":"2022-06-17","current":-1.015357,"twenty":-6.15727,"median":-4.04352,"eighty":-1.12564,"marketCap":71613161},{"date":"2022-06-24","current":-1.002505,"twenty":-6.141096,"median":-3.811017,"eighty":-1.072056,"marketCap":70706666},{"date":"2022-07-01","current":-1.045347,"twenty":-6.100661,"median":-3.677076,"eighty":-1.066768,"marketCap":73728318},{"date":"2022-07-08","current":-1.182442,"twenty":-6.096617,"median":-3.260088,"eighty":-1.066768,"marketCap":83397606},{"date":"2022-07-15","current":-1.27241,"twenty":-5.897474,"median":-3.073075,"eighty":-1.066768,"marketCap":89743076},{"date":"2022-07-22","current":-1.203863,"twenty":-5.791331,"median":-2.820355,"eighty":-1.066768,"marketCap":84908432},{"date":"2022-07-29","current":-1.135315,"twenty":-5.591177,"median":-2.643451,"eighty":-1.070195,"marketCap":80073788},{"date":"2022-08-05","current":-1.195294,"twenty":-5.512328,"median":-2.506983,"eighty":-1.071052,"marketCap":84304101},{"date":"2022-08-12","current":-1.250989,"twenty":-5.504241,"median":-2.451384,"eighty":-1.071855,"marketCap":88232250},{"date":"2022-08-19","current":-1.008852,"twenty":-5.469241,"median":-2.395786,"eighty":-1.066768,"marketCap":88724535},{"date":"2022-08-26","current":-0.940916,"twenty":-5.313533,"median":-2.360405,"eighty":-1.061627,"marketCap":82749819},{"date":"2022-09-02","current":-0.930726,"twenty":-5.276793,"median":-2.314915,"eighty":-1.048774,"marketCap":81853611},{"date":"2022-09-09","current":-0.913742,"twenty":-5.234336,"median":-2.292171,"eighty":-1.039901,"marketCap":80359932},{"date":"2022-09-16","current":-0.750695,"twenty":-5.145379,"median":-2.22899,"eighty":-1.023926,"marketCap":66020614},{"date":"2022-09-23","current":-0.655584,"twenty":-5.104944,"median":-1.912825,"eighty":-1.019402,"marketCap":57656011},{"date":"2022-09-30","current":-0.669171,"twenty":-5.092813,"median":-1.713484,"eighty":-1.014114,"marketCap":58850954},{"date":"2022-10-07","current":-0.65041,"twenty":-5.081694,"median":-1.594728,"eighty":-1.005075,"marketCap":57200979},{"date":"2022-10-14","current":-0.617524,"twenty":-5.073607,"median":-1.548073,"eighty":-0.983479,"marketCap":54308795},{"date":"2022-10-21","current":-0.61387,"twenty":-5.069563,"median":-1.480212,"eighty":-0.968263,"marketCap":53987441},{"date":"2022-10-28","current":-0.68695,"twenty":-5.033171,"median":-1.314802,"eighty":-0.940828,"marketCap":60414518},{"date":"2022-11-04","current":-0.484681,"twenty":-4.978584,"median":-1.27452,"eighty":-0.92665,"marketCap":49168502},{"date":"2022-11-11","current":-0.47201,"twenty":-4.952301,"median":-1.27241,"eighty":-0.914661,"marketCap":47883051},{"date":"2022-11-18","current":-0.443499,"twenty":-4.948257,"median":-1.248965,"eighty":-0.896339,"marketCap":44990786},{"date":"2022-11-25","current":-0.481514,"twenty":-4.926018,"median":-1.240279,"eighty":-0.882491,"marketCap":48847139},{"date":"2022-12-02","current":-0.438748,"twenty":-4.892659,"median":-1.220999,"eighty":-0.86541,"marketCap":44508742},{"date":"2022-12-09","current":-0.392814,"twenty":-4.884572,"median":-1.212431,"eighty":-0.769717,"marketCap":39848982},{"date":"2022-12-16","current":-0.367471,"twenty":-4.872441,"median":-1.195294,"eighty":-0.689873,"marketCap":37278080},{"date":"2022-12-23","current":-0.405485,"twenty":-4.866376,"median":-1.17864,"eighty":-0.672428,"marketCap":41134433},{"date":"2022-12-30","current":-0.424492,"twenty":-4.857278,"median":-1.172214,"eighty":-0.663737,"marketCap":43062609},{"date":"2023-01-06","current":-0.459339,"twenty":-4.857278,"median":-1.165305,"eighty":-0.655584,"marketCap":46597600},{"date":"2023-01-13","current":-0.484681,"twenty":-4.821897,"median":-1.161021,"eighty":-0.65041,"marketCap":49168502},{"date":"2023-01-20","current":-0.503688,"twenty":-4.817854,"median":-1.148168,"eighty":-0.637308,"marketCap":51096678},{"date":"2023-01-27","current":-0.503688,"twenty":-4.8128,"median":-1.133871,"eighty":-0.620447,"marketCap":51096678},{"date":"2023-02-03","current":-0.510024,"twenty":-4.807745,"median":-1.10961,"eighty":-0.601446,"marketCap":51739404},{"date":"2023-02-10","current":-0.478346,"twenty":-4.782473,"median":-1.075336,"eighty":-0.518894,"marketCap":48525776},{"date":"2023-02-17","current":-0.535367,"twenty":-4.74406,"median":-1.071052,"eighty":-0.515093,"marketCap":54310306},{"date":"2023-02-24","current":-0.715935,"twenty":-4.699581,"median":-1.066768,"eighty":-0.51636,"marketCap":72627983},{"date":"2023-03-03","current":-0.719102,"twenty":-4.648026,"median":-1.066768,"eighty":-0.518261,"marketCap":72949346},{"date":"2023-03-10","current":-0.56071,"twenty":-4.611634,"median":-1.062484,"eighty":-0.521429,"marketCap":56881208},{"date":"2023-03-17","current":-0.874327,"twenty":-4.569178,"median":-1.053916,"eighty":-0.530299,"marketCap":88696121},{"date":"2023-03-24","current":-0.621811,"twenty":-4.467079,"median":-1.045347,"eighty":-0.535367,"marketCap":75063167},{"date":"2023-03-31","current":-1.128264,"twenty":-4.406426,"median":-1.049631,"eighty":-0.539965,"marketCap":136200588},{"date":"2023-04-06","current":-1.0326,"twenty":-4.396317,"median":-1.049631,"eighty":-0.550102,"marketCap":124652408},{"date":"2023-04-14","current":-0.996023,"twenty":-4.375089,"median":-1.049631,"eighty":-0.561512,"marketCap":120236928},{"date":"2023-04-21","current":-0.93131,"twenty":-4.350827,"median":-1.045347,"eighty":-0.564447,"marketCap":112424924},{"date":"2023-04-28","current":-0.796256,"twenty":-4.333642,"median":-1.038157,"eighty":-0.578468,"marketCap":96121612},{"date":"2023-05-05","current":-0.83137,"twenty":-4.313425,"median":-1.028722,"eighty":-0.598523,"marketCap":100360456},{"date":"2023-05-12","current":-0.880615,"twenty":-4.299272,"median":-1.023926,"eighty":-0.605036,"marketCap":106305152},{"date":"2023-05-19","current":-1.116393,"twenty":-4.286131,"median":-1.028722,"eighty":-0.610485,"marketCap":121217968},{"date":"2023-05-26","current":-0.929527,"twenty":-4.262881,"median":-1.029233,"eighty":-0.615332,"marketCap":100927993},{"date":"2023-06-02","current":-0.990896,"twenty":-4.248728,"median":-1.023926,"eighty":-0.617524,"marketCap":107591516},{"date":"2023-06-09","current":-0.889112,"twenty":-4.231543,"median":-1.019642,"eighty":-0.617565,"marketCap":96539820},{"date":"2023-06-16","current":-0.904081,"twenty":-4.19313,"median":-1.019043,"eighty":-0.617984,"marketCap":98165069},{"date":"2023-06-23","current":-0.814271,"twenty":-4.185043,"median":-1.018532,"eighty":-0.618997,"marketCap":88413572},{"date":"2023-06-30","current":-0.773857,"twenty":-4.071825,"median":-1.015357,"eighty":-0.620742,"marketCap":84025399},{"date":"2023-07-07","current":-0.724462,"twenty":-4.04352,"median":-1.008852,"eighty":-0.621558,"marketCap":78662075},{"date":"2023-07-14","current":-0.832233,"twenty":-4.001063,"median":-1.004647,"eighty":-0.623624,"marketCap":90363872},{"date":"2023-07-21","current":-0.769367,"twenty":-3.875713,"median":-0.998221,"eighty":-0.627024,"marketCap":83537824},{"date":"2023-07-28","current":-0.82668,"twenty":-3.765527,"median":-0.993459,"eighty":-0.629636,"marketCap":89760926},{"date":"2023-08-04","current":-0.868894,"twenty":-3.713973,"median":-0.985075,"eighty":-0.631445,"marketCap":94344463},{"date":"2023-08-11","current":-0.851305,"twenty":-3.672527,"median":-0.976564,"eighty":-0.632998,"marketCap":92434656},{"date":"2023-08-18","current":-0.898223,"twenty":-3.445079,"median":-0.976328,"eighty":-0.635471,"marketCap":88851359},{"date":"2023-08-25","current":-0.935024,"twenty":-3.25099,"median":-0.975262,"eighty":-0.637855,"marketCap":92491636},{"date":"2023-08-31","current":-0.935024,"twenty":-3.192359,"median":-0.973294,"eighty":-0.638939,"marketCap":92491636},{"date":"2023-09-08","current":-0.943887,"twenty":-3.141815,"median":-0.974334,"eighty":-0.640637,"marketCap":93368334},{"date":"2023-09-15","current":-0.966044,"twenty":-3.044538,"median":-0.974596,"eighty":-0.646397,"marketCap":95560079},{"date":"2023-09-22","current":-0.771062,"twenty":-2.921525,"median":-0.969731,"eighty":-0.650765,"marketCap":76272724},{"date":"2023-09-29","current":-0.904004,"twenty":-2.859779,"median":-0.965073,"eighty":-0.652187,"marketCap":89423193},{"date":"2023-10-06","current":-0.89071,"twenty":-2.744539,"median":-0.959532,"eighty":-0.652265,"marketCap":88108146},{"date":"2023-10-13","current":-0.864122,"twenty":-2.691973,"median":-0.95275,"eighty":-0.652875,"marketCap":85478053},{"date":"2023-10-20","current":-0.771062,"twenty":-2.629299,"median":-0.948916,"eighty":-0.654368,"marketCap":76272724},{"date":"2023-10-27","current":-0.691297,"twenty":-2.600994,"median":-0.945798,"eighty":-0.654976,"marketCap":68382442},{"date":"2023-11-03","current":-0.771062,"twenty":-2.545396,"median":-0.940916,"eighty":-0.655584,"marketCap":76272724},{"date":"2023-11-10","current":-0.697312,"twenty":-2.502939,"median":-0.938487,"eighty":-0.655584,"marketCap":65752348},{"date":"2023-11-17","current":-0.690685,"twenty":-2.474634,"median":-0.935024,"eighty":-0.65966,"marketCap":65127425},{"date":"2023-11-24","current":-0.728273,"twenty":-2.460482,"median":-0.935024,"eighty":-0.665095,"marketCap":68671775},{"date":"2023-12-01","current":-0.747067,"twenty":-2.441275,"median":-0.93131,"eighty":-0.669171,"marketCap":70443949},{"date":"2023-12-08","current":-0.977295,"twenty":-2.416003,"median":-0.930726,"eighty":-0.670259,"marketCap":92153091},{"date":"2023-12-15","current":-0.831641,"twenty":-2.396796,"median":-0.924102,"eighty":-0.671891,"marketCap":78418736},{"date":"2023-12-22","current":-0.784655,"twenty":-2.384666,"median":-0.920535,"eighty":-0.672068,"marketCap":73988299},{"date":"2023-12-29","current":-0.841038,"twenty":-2.375568,"median":-0.91698,"eighty":-0.672334,"marketCap":79304824},{"date":"2024-01-05","current":-0.9632,"twenty":-2.36647,"median":-0.920535,"eighty":-0.672474,"marketCap":90823960},{"date":"2024-01-12","current":-1.137046,"twenty":-2.342209,"median":-0.924102,"eighty":-0.674981,"marketCap":107216577},{"date":"2024-01-19","current":-1.021931,"twenty":-2.330078,"median":-0.930127,"eighty":-0.677698,"marketCap":96362006},{"date":"2024-01-26","current":-1.484737,"twenty":-2.317948,"median":-0.93131,"eighty":-0.680936,"marketCap":140001812},{"date":"2024-02-02","current":-1.743157,"twenty":-2.299752,"median":-0.935024,"eighty":-0.68368,"marketCap":164369216},{"date":"2024-02-09","current":-1.743157,"twenty":-2.293687,"median":-0.937011,"eighty":-0.685334,"marketCap":164369216},{"date":"2024-02-16","current":-2.626481,"twenty":-2.299752,"median":-0.940076,"eighty":-0.68714,"marketCap":247661433},{"date":"2024-02-23","current":-2.227106,"twenty":-2.305535,"median":-0.942402,"eighty":-0.688076,"marketCap":210002718},{"date":"2024-03-01","current":-2.988269,"twenty":-2.330078,"median":-0.94771,"eighty":-0.690807,"marketCap":281775799},{"date":"2024-03-08","current":-2.927188,"twenty":-2.389016,"median":-0.951922,"eighty":-0.691889,"marketCap":276016231},{"date":"2024-03-15","current":-2.227106,"twenty":-2.44633,"median":-0.953803,"eighty":-0.694552,"marketCap":210002718},{"date":"2024-03-22","current":-2.978041,"twenty":-2.463514,"median":-0.959532,"eighty":-0.695729,"marketCap":219749680},{"date":"2024-03-28","current":-3.308852,"twenty":-2.5272,"median":-0.963576,"eighty":-0.695729,"marketCap":244160175},{"date":"2024-04-05","current":-4.049404,"twenty":-2.643451,"median":-0.966044,"eighty":-0.696346,"marketCap":298805547},{"date":"2024-04-12","current":-4.151821,"twenty":-2.729849,"median":-0.970206,"eighty":-0.696927,"marketCap":306362886},{"date":"2024-04-19","current":-3.568833,"twenty":-2.927188,"median":-0.974596,"eighty":-0.696927,"marketCap":263344188},{"date":"2024-04-26","current":-3.387634,"twenty":-2.988269,"median":-0.976564,"eighty":-0.697312,"marketCap":249973512},{"date":"2024-05-03","current":-3.5187,"twenty":-3.030555,"median":-0.978065,"eighty":-0.699743,"marketCap":259644879},{"date":"2024-05-10","current":-3.598489,"twenty":-3.143409,"median":-0.983769,"eighty":-0.709023,"marketCap":265532518},{"date":"2024-05-17","current":-4.247436,"twenty":-3.277339,"median":-0.985368,"eighty":-0.709479,"marketCap":245514546},{"date":"2024-05-24","current":-3.890937,"twenty":-3.387634,"median":-0.992012,"eighty":-0.709599,"marketCap":224907809},{"date":"2024-05-31","current":-3.789857,"twenty":-3.432528,"median":-0.994328,"eighty":-0.710926,"marketCap":219065119},{"date":"2024-06-07","current":-3.606477,"twenty":-3.496972,"median":-0.998221,"eighty":-0.713593,"marketCap":208465194},{"date":"2024-06-14","current":-4.024176,"twenty":-3.528275,"median":-1.002505,"eighty":-0.715232,"marketCap":232609468},{"date":"2024-06-21","current":-3.443472,"twenty":-3.544174,"median":-1.006789,"eighty":-0.717202,"marketCap":199043038},{"date":"2024-06-28","current":-3.27028,"twenty":-3.546282,"median":-1.006789,"eighty":-0.718469,"marketCap":189031998},{"date":"2024-07-05","current":-2.934083,"twenty":-3.543661,"median":-1.012249,"eighty":-0.719102,"marketCap":169598802},{"date":"2024-07-12","current":-3.025773,"twenty":-3.528275,"median":-1.017751,"eighty":-0.722318,"marketCap":174898764},{"date":"2024-07-15","current":-3.209153,"twenty":-3.523487,"median":-1.018532,"eighty":-0.72339,"marketCap":185498689},{"date":"2024-08-02","current":-3.759294,"twenty":-3.542637,"median":-1.018787,"eighty":-0.724462,"marketCap":217298465},{"date":"2024-08-09","current":-3.54535,"twenty":-3.542637,"median":-1.01922,"eighty":-0.726748,"marketCap":204931886},{"date":"2024-08-16","current":-3.414893,"twenty":-3.535163,"median":-1.019642,"eighty":-0.728273,"marketCap":202171893},{"date":"2024-08-23","current":-3.633924,"twenty":-3.545198,"median":-1.023926,"eighty":-0.728273,"marketCap":215139186},{"date":"2024-08-30","current":-3.64388,"twenty":-3.568833,"median":-1.028147,"eighty":-0.728273,"marketCap":215728609},{"date":"2024-09-06","current":-3.484584,"twenty":-3.574764,"median":-1.029598,"eighty":-0.728273,"marketCap":206297850},{"date":"2024-09-13","current":-3.623968,"twenty":-3.60454,"median":-1.038157,"eighty":-0.730014,"marketCap":214549764},{"date":"2024-09-20","current":-3.663792,"twenty":-3.616003,"median":-1.045347,"eighty":-0.730587,"marketCap":216907454},{"date":"2024-09-27","current":-3.73382,"twenty":-3.623968,"median":-1.049631,"eighty":-0.732502,"marketCap":221053355},{"date":"2024-10-04","current":-3.52304,"twenty":-3.625864,"median":-1.057271,"eighty":-0.738629,"marketCap":208574536},{"date":"2024-10-11","current":-3.166721,"twenty":-3.623968,"median":-1.062484,"eighty":-0.745662,"marketCap":187479391},{"date":"2024-10-18","current":-3.242,"twenty":-3.616003,"median":-1.065075,"eighty":-0.747504,"marketCap":191936112},{"date":"2024-10-25","current":-3.763932,"twenty":-3.625864,"median":-1.066768,"eighty":-0.747613,"marketCap":222836043},{"date":"2024-10-31","current":-3.784006,"twenty":-3.637906,"median":-1.066768,"eighty":-0.748092,"marketCap":224024502},{"date":"2024-11-08","current":-3.954637,"twenty":-3.663792,"median":-1.071052,"eighty":-0.748411,"marketCap":234126403},{"date":"2024-11-15","current":-4.437354,"twenty":-3.685372,"median":-1.075336,"eighty":-0.749781,"marketCap":254513320},{"date":"2024-11-22","current":-2.177206,"twenty":-3.694157,"median":-1.080597,"eighty":-0.752917,"marketCap":124878030},{"date":"2024-11-29","current":-2.083898,"twenty":-3.693667,"median":-1.083246,"eighty":-0.755737,"marketCap":119526115},{"date":"2024-12-06","current":-1.7625,"twenty":-3.691387,"median":-1.086059,"eighty":-0.758203,"marketCap":101091739},{"date":"2024-12-13","current":-1.575883,"twenty":-3.686241,"median":-1.106883,"eighty":-0.759205,"marketCap":90387908},{"date":"2024-12-20","current":-1.596618,"twenty":-3.67968,"median":-1.116393,"eighty":-0.76056,"marketCap":91577222},{"date":"2024-12-27","current":-1.679559,"twenty":-3.673718,"median":-1.116393,"eighty":-0.762678,"marketCap":96334480},{"date":"2025-01-03","current":-1.752133,"twenty":-3.673597,"median":-1.123944,"eighty":-0.765861,"marketCap":100497082},{"date":"2025-01-10","current":-1.669192,"twenty":-3.665753,"median":-1.128264,"eighty":-0.766468,"marketCap":95739823},{"date":"2025-01-17","current":-1.524045,"twenty":-3.663792,"median":-1.133871,"eighty":-0.766629,"marketCap":87414621},{"date":"2025-01-24","current":-1.700295,"twenty":-3.658115,"median":-1.136181,"eighty":-0.768273,"marketCap":97523795},{"date":"2025-01-31","current":-1.679559,"twenty":-3.64806,"median":-1.148168,"eighty":-0.769367,"marketCap":96334480},{"date":"2025-02-07","current":-1.524045,"twenty":-3.64388,"median":-1.161021,"eighty":-0.770083,"marketCap":87414621},{"date":"2025-02-14","current":-1.347794,"twenty":-3.637906,"median":-1.165305,"eighty":-0.77056,"marketCap":77305447},{"date":"2025-02-21","current":-1.41,"twenty":-3.633924,"median":-1.174839,"eighty":-0.770761,"marketCap":80873391},{"date":"2025-02-28","current":-1.171544,"twenty":-3.633734,"median":-1.174839,"eighty":-0.771062,"marketCap":67196273},{"date":"2025-03-07","current":-1.223383,"twenty":-3.629657,"median":-1.181912,"eighty":-0.771062,"marketCap":70169560},{"date":"2025-03-14","current":-1.109339,"twenty":-3.623968,"median":-1.174839,"eighty":-0.771062,"marketCap":63628330},{"date":"2025-03-21","current":-0.892026,"twenty":-3.623745,"median":-1.171544,"eighty":-0.771314,"marketCap":68981264},{"date":"2025-03-28","current":-0.868132,"twenty":-3.619651,"median":-1.167447,"eighty":-0.772558,"marketCap":67133552},{"date":"2025-04-04","current":-0.745081,"twenty":-3.613757,"median":-1.161021,"eighty":-0.771314,"marketCap":57617833},{"date":"2025-04-11","current":-0.722621,"twenty":-3.613374,"median":-1.150809,"eighty":-0.771062,"marketCap":55880983},{"date":"2025-04-17","current":-0.743806,"twenty":-3.611995,"median":-1.149569,"eighty":-0.769606,"marketCap":57519288}],"updateTime":1745268627005}}}